Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Open-market sale Chief Executive Officer sold 20,000 shares at $46.00 ($920,000)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale President sold 50,000 shares at $45.00 ($2,250,000)
  11. 4 Shares withheld for taxes Chief Executive Officer gave up 741 shares (to pay taxes)
  12. 4 Open-market sale Chief Executive Officer sold 20,000 shares at $42.03 ($840,600)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award Ho Tony W acquired 10,000 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market sale President sold 85,220 shares at an average $40.40 ($3,443,037)
  19. 4 Shares withheld for taxes Chief Executive Officer gave up 748 shares (to pay taxes)
  20. 4 Open-market sale President sold 14,780 shares at $40.00 ($591,233)

Page 17 of 26 · 502 filings